Transcriptomics

Dataset Information

2

LNCaP and C42B LSD1 knockdown microarray gene expression data and C42B androgen (DHT) stimulation microarray gene expression data


ABSTRACT: LSD1 (also known as KDM1A) is a histone demethylase and a key regulator of gene expression in embryonic stem cells and cancer.1,2 LSD1 was initially identified as a transcriptional repressor via its demethylation of active histone H3 marks (di-methyl lysine 4 [2MK4]).1 In prostate cancer, specifically, LSD1 also co-localizes with the AR and demethylates repressive 2MK9 histone marks from androgen-responsive AR target genes, facilitating androgen-mediated induction of AR-regulated gene expression and androgen-induced proliferation in androgen-dependent cancers.3,4 Recently, it was shown that treatment with high doses of androgens (e.g.10-fold higher doses than those required for induction of expression of androgen-activated genes such as PSA) recruits LSD1 and AR to an enhancer within the AR; this AR and LSD1 recruitment represses AR transcription.5 Thus, LSD1 appears to play a role in mediating both the proliferative and repressive phases of the biphasic androgen dose-response curve. For these reasons, we hypothesized that LSD1 might be important for maintenance of AR signaling in castration-resistant prostate cancer (CRPC) tumors. However, in this report, we describe a distinct role of LSD1 as a driver of proliferation and survival of prostate cancer cells, including CRPC cells, irrespective of androgens or even AR expression. Specifically, LSD1 activates expression of cell cycle, mitosis, and embryonic stem cell maintenance pathways that are enriched in lethal prostate cancers – pathways not activated by androgens. Finally, we observe that treatment with a new LSD1 inhibitor potently and specifically suppresses LSD1 function and suppresses CRPC growth and survival in vitro and in vivo. Our data place LSD1 as a key driver of androgen-independent survival in lethal prostate cancers and demonstrate the potential of LSD1-directed therapies in the near-term. The enclosed files are from microarrays experiments after suppressing LSD1 with RNAi or stimulating cells with the androgen agonist dihydrotestosterone (DHT).

ORGANISM(S): Homo sapiens  

SUBMITTER: Joshi Alumkal   Armand Bankhead 

PROVIDER: E-GEOD-61630 | ArrayExpress | 2016-06-30

SECONDARY ACCESSION(S): GSE61630PRJNA261710

REPOSITORIES: GEO, ArrayExpress

Similar Datasets

2012-10-02 | E-GEOD-40050 | ArrayExpress
2014-09-10 | E-GEOD-58478 | ArrayExpress
2011-08-15 | E-GEOD-31410 | ArrayExpress
2016-06-10 | E-GEOD-69896 | ArrayExpress
2016-06-30 | E-GEOD-77762 | ArrayExpress
2016-02-12 | E-GEOD-55030 | ArrayExpress
2015-04-03 | E-GEOD-67537 | ArrayExpress
2015-03-02 | E-GEOD-60841 | ArrayExpress
2013-04-01 | E-GEOD-44905 | ArrayExpress
2016-02-12 | E-GEOD-71704 | ArrayExpress